CHRIS GLOVER to Cardiotonic Agents
This is a "connection" page, showing publications CHRIS GLOVER has written about Cardiotonic Agents.
Connection Strength
0.201
-
Impact of baseline beta-blocker use on inotrope response and clinical outcomes in cardiogenic shock: a subgroup analysis of the DOREMI trial. Crit Care. 2021 08 10; 25(1):289.
Score: 0.160
-
The association between mean arterial pressure and outcomes in patients with cardiogenic shock: insights from the DOREMI trial. Eur Heart J Acute Cardiovasc Care. 2021 Oct 01; 10(7):712-720.
Score: 0.040